{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:31:00Z","timestamp":1760866260946,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Post-transplant lymphoproliferative disorder (PTLD) of T cell type has been rarely reported. Accurate diagnosis of this life-threatening rare form of PTLD is important for the treatment strategy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 7-year-old boy had severe diarrhea and weight loss progressively at 7\u2009years post-living donor liver transplantation (LDLT) for biliary atresia. Endoscopy in the gastrointestinal (GI) tract revealed multiple erosions and ulcer lesions with prominent intraepithelial lymphocytosis in the duodenum and terminal ileum. Immunohistochemical examination demonstrated that these accumulated lymphocytes mainly comprised small- to medium-sized T cells expressing CD3, CD4, CD5, CD7, and CD103, but lacking CD8, CD56, and Epstein-Barr virus-encoded small RNAs. In addition, T cell receptor \u03b2 gene rearrangement was detected by polymerase chain reaction analysis. Comprehensively, the lesions were best interpreted as post-transplant indolent T cell lymphoproliferative disorder (LPD) of the intestine. Clinical remission was achieved by reducing the immunosuppressant.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>A rarely reported indolent type of T cell LPD in post-LDLT was diagnosed by direct inspection and histological investigation. Although the histological classification and therapeutic strategy for post-transplant indolent T cell LPD have not been established, reducing immunosuppression allowed complete remission in our case. To prevent the incidence of PTLD and de novo malignancy, developing a methodology to set a proper dose of immunosuppressant is required.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40792-020-00904-y","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T02:02:43Z","timestamp":1593136963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-0034","authenticated-orcid":false,"given":"Ryoichi","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Koshizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Shiratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Ara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"904_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","volume":"79","author":"IM Ghobrial","year":"2005","unstructured":"Ghobrial IM, Habermann TM, Macon WR, Ristow KM, Larson TS, Walker RC, et al. Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation. 2005;79:244\u20137.","journal-title":"Transplantation."},{"key":"904_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/TP.0b013e3182762e07","volume":"95","author":"C Tiede","year":"2013","unstructured":"Tiede C, Maecker-Kolhoff B, Klein C, Kreipe H, Hussein K. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases. Transplantation. 2013;95:479\u201388.","journal-title":"Transplantation."},{"key":"904_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3324\/haematol.2016.144428","volume":"101","author":"J Styczynski","year":"2016","unstructured":"Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, et al. Management of Epstein-Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. 2016;101:803\u201311.","journal-title":"Haematologica."},{"key":"904_CR4","doi-asserted-by":"publisher","first-page":"37636","DOI":"10.18632\/oncotarget.9400","volume":"7","author":"E Margolskee","year":"2016","unstructured":"Margolskee E, Jobanputra V, Jain P, Chen J, Ganapathi K, Nahum O, et al. Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders. Oncotarget. 2016;7:37636\u201348.","journal-title":"Oncotarget."},{"key":"904_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","volume":"127","author":"SH Swerdlow","year":"2007","unstructured":"Swerdlow SH. T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 2007;127:887\u201395.","journal-title":"Am J Clin Pathol."},{"key":"904_CR6","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.transproceed.2017.03.075","volume":"49","author":"IE Obiorah","year":"2017","unstructured":"Obiorah IE, Ozdemirli M. An unusual posttransplant T-cell lymphoma after liver transplantation: a case report. Transplantation Proceedings. 2017;49:1639\u201343.","journal-title":"Transplantation Proceedings."},{"key":"904_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4:222\u201330.","journal-title":"Am J Transplant."},{"key":"904_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","volume":"12","author":"S Caillard","year":"2012","unstructured":"Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, et al. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant. 2012;12:682\u201393.","journal-title":"Am J Transplant."},{"issue":"Suppl 3","key":"904_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ajt.12004","volume":"13","author":"M Green","year":"2013","unstructured":"Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13(Suppl 3):41\u201354 quiz.","journal-title":"Am J Transplant"},{"key":"904_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00277-017-3026-6","volume":"96","author":"K Teiken","year":"2017","unstructured":"Teiken K, Kreipe H, Maecker-Kolhoff B, Hussein K. Variant of classical high grade PTLD: post-transplant EBV-negative T cell lymphoblastic leukaemia after solid organ transplantation. Ann Hematol. 2017;96:1403\u20135.","journal-title":"Ann Hematol."},{"key":"904_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/MOT.0b013e3283465715","volume":"16","author":"KY Kamdar","year":"2011","unstructured":"Kamdar KY, Rooney CM, Heslop HE. Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant. 2011;16:274\u201380.","journal-title":"Curr Opin Organ Transplant."},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N","volume":"91","author":"Y Hoshida","year":"2001","unstructured":"Hoshida Y, Li T, Dong Z, Tomita Y, Yamauchi A, Hanai J, et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer. 2001;91:869\u201375.","journal-title":"Int J Cancer."},{"key":"904_CR13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood."},{"key":"904_CR14","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","volume":"122","author":"AM Perry","year":"2013","unstructured":"Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013;122:3599\u2013606.","journal-title":"Blood."},{"key":"904_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.cgh.2013.11.028","volume":"12","author":"G Malamut","year":"2014","unstructured":"Malamut G, Meresse B, Kaltenbach S, Derrieux C, Verkarre V, Macintyre E, et al. Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features. Clin Gastroenterol Hepatol. 2014;12:599\u2013608 e1.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"904_CR16","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/1097-0142(19940215)73:4<1286::AID-CNCR2820730425>3.0.CO;2-9","volume":"73","author":"F Carbonnel","year":"1994","unstructured":"Carbonnel F, Lavergne A, Messing B, Tsapis A, Berger R, Galian A, et al. Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation. Cancer. 1994;73:1286\u201391.","journal-title":"Cancer."},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hon.2317","volume":"35","author":"R Matnani","year":"2017","unstructured":"Matnani R, Ganapathi KA, Lewis SK, Green PH, Alobeid B, Bhagat G. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Hematol Oncol. 2017;35:3\u201316.","journal-title":"Hematol Oncol."},{"key":"904_CR18","doi-asserted-by":"publisher","first-page":"e68343","DOI":"10.1371\/journal.pone.0068343","volume":"8","author":"E Margolskee","year":"2013","unstructured":"Margolskee E, Jobanputra V, Lewis SK, Alobeid B, Green PH, Bhagat G. Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS One. 2013;8:e68343.","journal-title":"PLoS One."},{"key":"904_CR19","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","volume":"132","author":"Y Natkunam","year":"2018","unstructured":"Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, et al. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. 2018;132:1871\u20138.","journal-title":"Blood."},{"key":"904_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.pathol.2017.03.012","volume":"49","author":"G Soon","year":"2017","unstructured":"Soon G, Wang S. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract in a renal transplant patient: diagnostic pitfalls and clinical challenges. Pathology. 2017;49:547\u201350.","journal-title":"Pathology."}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-00904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-020-00904-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-00904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:08:10Z","timestamp":1624662490000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-020-00904-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s40792-020-00904-y","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and his family for the publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}